Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on August 3, 2026

Aug. 3, 2026

Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System

Indeterminate GlobeNewswire

Aug. 3, 2026

Adlai Nortye Announces Clinical Trial Notification Submission and HREC Approval for the Phase I Clinical Trial of Pan-RAS(ON) Inhibitor ADC AN4035 in Australia

Indeterminate GlobeNewswire

Aug. 3, 2026

Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Aug. 3, 2026

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

Indeterminate GlobeNewswire

Aug. 3, 2026

Palomino Laboratories Completes Vega Links Acquisition and Strengthens Technology Leadership to Accelerate Next-Generation AI Interconnect Development

Indeterminate GlobeNewswire

Aug. 3, 2026

Opus Genetics Completes Patient Enrollment in Registrational Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease

Indeterminate GlobeNewswire

Aug. 3, 2026

Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S.

Indeterminate GlobeNewswire

Aug. 3, 2026

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

Indeterminate GlobeNewswire

Aug. 3, 2026

Aurora Mobile's GPTBots.ai Launches LoopAgent: Production-Grade Execution That Runs Complex Tasks End-to-End

Indeterminate GlobeNewswire

Aug. 3, 2026

Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für Juli 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt

Indeterminate GlobeNewswire

Aug. 3, 2026

Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for July 2026 of its Virtune Crypto Altcoin Index ETP

Indeterminate GlobeNewswire

Aug. 3, 2026

Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för juli 2026 av Virtune Crypto Altcoin Index ETP

Indeterminate GlobeNewswire

Aug. 3, 2026

Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026

Indeterminate GlobeNewswire

Aug. 3, 2026

Supernus Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 3, 2026

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

Indeterminate GlobeNewswire

Aug. 3, 2026

Diginex Announces Secured US$70 Million Funding Commitments and Extension of Long-Stop Date for Proposed Acquisition of Resulticks

Indeterminate GlobeNewswire

Aug. 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Indeterminate GlobeNewswire

Aug. 3, 2026

Texas Precious Metals Rings Nasdaq Closing Bell to Celebrate Launch of Y'all Street Physical Gold and Silver ETFs 

Indeterminate GlobeNewswire

Aug. 3, 2026

BioNTech ernennt Dr. Guido Oelkers zum neuen Vorstandsvorsitzenden

Indeterminate GlobeNewswire

Aug. 3, 2026

BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer

Indeterminate GlobeNewswire